factors that might have affected the results of the study, the researchers noted.
Spatz said, “We need to capture factors in the community that may undermine differences in response to cardiovascular interventions, and specifically to blood pressure-lowering therapy.”
Kim Stitzel, a senior vice president in the Center for Health Metrics and Evaluation at the American Heart Association, said this study shows the importance of taking socioeconomic factors into account when evaluating a clinical trial.
“Although patients had equal access, in theory, to resources like medications, health care providers and other assets, patients may not access these resources equally in practice,” she said.
Stitzel believes that other factors that affect
